Insider · CIK 0001638363

Thompson Danny L

Reports to the SEC for 1 company · CORALVILLE, IA

sec.gov

Transactions

Companies

Filings

CIK

0001638363

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-30	ZVRAZEVRA THERAPEUTICS, INC.A Award	Director	AAward	+8,214 sh	—	—	31,727
2019-05-10	ZVRAZEVRA THERAPEUTICS, INC.A Award	Director	AAward	+8,873 sh	—	—	23,513
2019-04-24	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-05-22	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-03-23	ZVRAZEVRA THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$4.65	+$15.5K	16,666
2018-03-23	ZVRAZEVRA THERAPEUTICS, INC.F Tax Payment	Director	FTax Payment	−2,026 sh	$7.65	−$15.5K	14,640
2018-03-23	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	0
2017-05-23	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-05-24	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-04-04	ZVRAZEVRA THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+13.3K sh	$4.65	+$62K	13,333
2016-04-04	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.3K sh	—	—	0
2015-08-25	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC.C Conversion	Director	CConversion	+7,373 sh	—	—	7,373
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC.C Conversion	Director	CConversion	+91.7K sh	—	—	91,687
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−26.4K sh	—	—	0
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−16.1K sh	—	—	0
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−12.8K sh	—	—	0
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−270K sh	—	—	0
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−161K sh	—	—	0
2015-04-21	ZVRAZEVRA THERAPEUTICS, INC. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−256K sh	—	—	0

Recent filings

Accepted (ET)
Jul 24
Thompson Danny L0001437749-19-013394
SEC(opens sec.gov)
May 144
Thompson Danny L0001437749-19-009883
SEC(opens sec.gov)
Apr 264
Thompson Danny L0001437749-19-008065
SEC(opens sec.gov)
May 244
Thompson Danny L0001437749-18-010653
SEC(opens sec.gov)
Mar 274
Thompson Danny L0001437749-18-005591
SEC(opens sec.gov)
May 244
KEMPHARM, INC0001437749-17-010012
SEC(opens sec.gov)
May 264
KEMPHARM, INC0001209191-16-123560
SEC(opens sec.gov)
Apr 64
KEMPHARM, INC0001209191-16-113477
SEC(opens sec.gov)
Aug 274
KEMPHARM, INC0001209191-15-068246
SEC(opens sec.gov)
Apr 214
KEMPHARM, INC0001209191-15-035360
SEC(opens sec.gov)

Companies

ZEVRA THERAPEUTICS, INC.DirectorZVRA

Address

C/O KEMPHARM, INC. 2656 CROSSPARK ROAD, SUITE 100

CORALVILLE, IA, 52241